Clinical trial
In Vivo PET of Synaptic Density in Cognitive Disorders
NCT05384353 · Universitaire Ziekenhuizen KU Leuven, Other · Completed
Key facts
| NCT number | NCT05384353 |
|---|---|
| Title | In Vivo PET of Synaptic Density in Cognitive Disorders |
| Official title | In Vivo PET of Synaptic Density in Cognitive Disorders: Prospective Evaluation of Neuronal Dysfunction and Relation to Symptomatology |
| Lead sponsor | Universitaire Ziekenhuizen KU Leuven, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Alzheimer Disease, Frontotemporal Degeneration, Dementia With Lewy Bodies, Psychiatric Disorder |
| Intervention type | Other |
| Interventions | [18F]-SynVesT-1 |
| Enrollment | 134 |
| Start date | Apr 11, 2022 |
| Primary completion | May 28, 2025 |
| Completion | Jun 4, 2025 |
| First posted | May 20, 2022 |
| Last update posted | Jan 8, 2026 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: